NutriStack
Chromium Picolinate and Insulin Glargine, a caution.
Chromium enhances insulin signaling by potentiating insulin receptor tyrosine kinase activity and increasing GLUT4 translocation. While this effect is generally modest and clinically meaningful primarily in chromium-deficient individuals, it creates a pharmacodynamic synergism with exogenous insulin that could contribute to hypoglycemia, particularly at higher chromium doses (>200 mcg/day).
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Chromium Picolinate and Insulin Glargine
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 1 source
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. Chromium enhances insulin signaling by potentiating insulin receptor tyrosine kinase activity and increasing GLUT4 translocation. While this effect is generally modest and clinically meaningful primarily in chromium-deficient individuals, it creates a pharmacodynamic synergism with exogenous insulin that could contribute to hypoglycemia, particularly at higher chromium doses (>200 mcg/day).
Mechanism. Chromium enhances insulin receptor signaling by activating insulin receptor tyrosine kinase, promoting IRS-1 phosphorylation, and increasing GLUT4 translocation to the plasma membrane. It may also increase insulin receptor number and binding affinity on cell surfaces. These effects potentiate the glucose-lowering action of exogenous insulin glargine.
Recommendation. Low-dose chromium in standard multivitamins is generally safe with insulin therapy. High-dose chromium supplements (>200 mcg/day) require more frequent blood glucose monitoring and possible insulin dose adjustment. Discuss any chromium supplementation with your prescriber. Monitor for hypoglycemia symptoms.
Stack Score
How this pair moves the number.
Effect on the composite score
If both Chromium Picolinate and Insulin Glargine are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.